You're reading the free version. Trader adds the live tape and alerts.
Start tracking
GLUE Sale Disclosure
Warmuth Markus · SEC Form 4 · Filed Jun 2, 2026
Sale
Calculated transaction value
$9.23K
Warmuth Markus President & CEO
GLUE
Transaction date
Jun 1, 2026
Public filing date
Jun 2, 2026
Filing lag
Filed 1 day later
GLUE daily price context
Close on/before transaction
$19.67
Jun 1, 2026
First close after public filing
$17.59
Jun 3, 2026
30-day return after filing
+37.64%
Through Jul 2, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 468 shares @ $19.73
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001193125-26-253472
Filing cohort
Transactions in this filing
Showing 2 of 2
Trades
2
Issuers
1
Estimated value
$106.25K
Buys / sales
0 / 2
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Monte Rosa Therapeutics, Inc. GLUE | Sale | Jun 1, 2026 | $97.02K |
| Monte Rosa Therapeutics, Inc. GLUE Current | Sale | Jun 1, 2026 | $9.23K |